Estimating Survival in Patients With Lung Cancer and Brain Metastases
Paul W. Sperduto(Methodist Hospital), Minesh P. Mehta(Columbia University), Kathryn Beal(Memorial Sloan Kettering Cancer Center), David Roberge(Centre Hospitalier de l’Université de Montréal), Nils D. Arvold(Dana-Farber Cancer Institute), Penny K. Sneed(University of California, San Francisco), Joseph N. Contessa(Memorial Sloan Kettering Cancer Center), Helen A. Shih(Massachusetts General Hospital), Brian M. Alexander(Brigham and Women's Hospital), Kimberley S. Mak(Massachusetts General Hospital), J. Daniel(Mayo Clinic), Veronica Chiang(Yale University), Jonathan T. Yang(New York University), Emil Lou(University of Minnesota), Hubert Y. Pan(The University of Texas MD Anderson Cancer Center), Paul D. Brown(Mayo Clinic), William Sperduto(Duke University), Steve Braunstein(University of California, San Francisco), Ryan Shanley(Apple (Israel)), Mark M. Awad(Memorial Sloan Kettering Cancer Center), John P. Kirkpatrick(Duke University), John Boyle(Ocean Institute), Norman Yeh(University of Denver), Laurie E. Gaspar(University of Colorado Cancer Center), Ananta Bangdiwala(RTI International), Alex Engelman(University of Maryland, Baltimore), J. Hardie(Mayo Clinic)
Cited by 655
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
|Medicine|2000|1.7k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k